BIOSPECIFICS TECHNOLOGIES CORP 4
4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed May 19, 2016
Insider Transaction Report
Form 4
Wegman Toby
Director10% Owner
Transactions
- Sale
Common Stock, $0.001 par value
2016-05-18$33.80/sh−50$1,690→ 1,005,128 total(indirect: See footnote) - Sale
Common Stock, $0.001 par value
2016-05-18$34.14/sh−150$5,121→ 1,004,978 total(indirect: See footnote) - Sale
Common Stock, $0.001 par value
2016-05-18$33.00/sh−24,750$816,750→ 980,178 total(indirect: See footnote) - Sale
Common Stock, $0.001 par value
2016-05-18$34.11/sh−50$1,706→ 1,004,928 total(indirect: See footnote)
Footnotes (5)
- [F1]The selling price of $33.80 is reflective of the sale price of all transactions reported on this line.
- [F2]The selling price of $34.14 is reflective of the sale price of all transactions reported on this line.
- [F3]The selling price of $34.11 is reflective of the sale price of all transactions reported on this line.
- [F4]The selling price of $33.00 is reflective of the sale price of all transactions reported on this line.
- [F5]These shares are held in trust on behalf of the reporting person and Mr. Thomas Wegman. The reporting person is the co-trustee of the trust with Mr. Thomas Wegman. The reporting person disclaims beneficial ownership of the shares held by the trust except to the extent of the reporting person's pecuniary interest therein.